Date of Award
2012
Document Type
Thesis
Publication Status
Version of Record
Submission Date
October 2026
Abstract
Huntington's disease (HD) is caused by an expanded plyglutamine repeat in the huntingtin protein. In this study, I focused on the effect of the mutant huntingtin protein (mhtt) on the subcellular localization of glutamic acid decarboxylase (GAD), the enzyme responsible for synthesizing gama-aminobutyric acid (GABA). Subcellular distribution of GAD65 is significantly altered in two neuronal cell lines that express either the N-terminus or full length mhtt. GAD65 is predominantly associated with the Golgi membrane in cells expressing normal huntingtin (Htt). However, it diffuses in the cytosol of cells expressing mhtt. Palmitoylation of GAD65 is required for GAD65 trafficking, and I demonstrated the palmitoylation of GAD65 is reduced in the HD model. Overexpression of huntingtin-interacting protein 14 (HIP14), the enzyme that palmitoylates GAD65, rescues GAD65 palmitoylation and vesicle-associated trafficking. This data suggests that impairment of GAD65 palmitoylation by mhtt may alter its localization and lead to altered inhibitory neurotransmission in HD.
Extent
x, 39 p. : ill. (some col.)
Recommended Citation
Rush, Daniel., "Mutant huntingtin reduces palmitoylation of GAD65 and impairs its vesicular trafficking" (2012). Electronic Theses and Dissertations 2010 - 2019. 589.
https://digitalcommons.fau.edu/etd_general_6/589
Identifier
FADT3352831
Comments
by Daniel Rush.|Thesis (M.S.)--Florida Atlantic University, 2012.|Includes bibliography.|Electronic reproduction. Boca Raton, Fla., 2012. Mode of access: World Wide Web.|by Daniel Rush.